- Home
- ATRC vs OCUL Comparison
ATRC vs OCUL Comparison
Compare ATRC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRC | OCUL |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ATRC | OCUL |
|---|---|---|
| Price | $29.95 | $8.30 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $51.17 | $22.90 |
| AVG Volume (30 Days) | 545.5K | ★ 5.2M |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $201,630,000.00 | $1,990,000.00 |
| Revenue This Year | $15.17 | $9.35 |
| Revenue Next Year | $12.42 | $92.88 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | 3.48 |
| 52 Week Low | $28.32 | $6.23 |
| 52 Week High | $43.18 | $16.44 |
Technical Indicators
Market Signals| Indicator | ATRC | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 42.21 | 39.84 |
| Support Level | $28.69 | $6.23 |
| Resistance Level | $32.85 | $12.38 |
| Average True Range (ATR) | 1.14 | 0.45 |
| MACD | 0.20 | -0.14 |
| Stochastic Oscillator | 37.59 | 8.26 |
Price Performance
Historical ComparisonAbout ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.